Albemarle shares surged roughly 80% in 2025, driving several firms to lift their assessments. Robert Baird moved the rating from Neutral to Outperform and more than doubled its target from $113 to $210. Scotiabank raised its view from Sector Perform to Sector Outperform, boosting its target from $85 to $200. Deutsche Bank shifted from Hold to Buy and affirmed a target of $185. These upgrades reflect growing confidence in Albemarle’s ability to capitalize on improving market conditions for lithium.

Lithium prices have rebounded above $15 per kilogram after a supply glut in 2023–24, and some analysts foresee further gains to $17 per kilogram in 2026. Structural demand drivers include grid-scale energy storage, electric vehicles and power systems for AI data centers. Governments worldwide are incentivizing domestic output and stockpiling, tightening global supply. Albemarle benefits as one of the top lithium producers, with additional upside from its catalyst materials business and strong pricing power in its bromine segment.

Despite trading more than 23% above the consensus price target, Albemarle’s chart exhibits sustained momentum rather than exhaustion. The 14-day relative strength index hovers around 80 and the MACD remains firmly positive. Since November, the stock has climbed almost parabolically with only shallow pullbacks, indicating a robust uptrend. Analysts estimate 20–30% additional upside in 2026, but they advise disciplined risk management—tightening stops, trimming into strength or adding hedges—rather than outright selling or aggressive fading.